3,632
edits
No edit summary Tags: Mobile edit Mobile web edit Advanced mobile edit |
No edit summary |
||
Line 1: | Line 1: | ||
{{Stub Notice}} | |||
[https://pubmed.ncbi.nlm.nih.gov/31584918/ Retrospective Analysis of the Safety and Efficacy of Sugammadex Versus Neostigmine for the Reversal of Neuromuscular Blockade in Children] | [https://pubmed.ncbi.nlm.nih.gov/31584918/ Retrospective Analysis of the Safety and Efficacy of Sugammadex Versus Neostigmine for the Reversal of Neuromuscular Blockade in Children] | ||
[https://pubmed.ncbi.nlm.nih.gov/34878707/ Sugammadex for reversal of neuromuscular blockade in pediatric patients: Results from a phase IV randomized study] | |||
[https://pubmed.ncbi.nlm.nih.gov/10983014/ Neuromuscular blockade in children] | [https://pubmed.ncbi.nlm.nih.gov/10983014/ Neuromuscular blockade in children] | ||
[[TYK6 |Test Your Knowledge]]: unique advantage of rocuronium | [[TYK6 |Test Your Knowledge]]: unique advantage of rocuronium | ||
[https://pubmed.ncbi.nlm.nih.gov/21474022/ Assessment of neuromuscular blockade in children at the time of block reversal and the removal of the endotracheal tube] | [https://pubmed.ncbi.nlm.nih.gov/21474022/ Assessment of neuromuscular blockade in children at the time of block reversal and the removal of the endotracheal tube] | ||
[https://www.bjanaesthesia.org/article/S0007-0912(19)30835-9/fulltext Comparison of incidence of anaphylaxis between sugammadex and neostigmine: a retrospective multicentre observational study] | [https://www.bjanaesthesia.org/article/S0007-0912(19)30835-9/fulltext Comparison of incidence of anaphylaxis between sugammadex and neostigmine: a retrospective multicentre observational study] |